{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:36:25Z","timestamp":1790825785269,"version":"4.1.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/ajg.2016.318","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T08:05:16Z","timestamp":1471334716000},"page":"102-110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":215,"title":["Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver"],"prefix":"10.14309","volume":"112","author":[{"given":"Alexandra","family":"Feldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian K","family":"Eder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas K","family":"Felder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmyla","family":"Kedenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Paulweber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Stadlmayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Huber-Sch\u00f6nauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Niederseer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Stickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Auer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Haschke-Becher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Patsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Datz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20210210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4103\/2156-7514.157860","article-title":"The global nonalcoholic fatty liver disease epidemic: what a radiologist needs to know.","volume":"5","author":"Pereira","year":"2015","journal-title":"J Clin Imag Sci"},{"key":"R2-23-20210210","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/cob.12068","article-title":"Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.","volume":"4","author":"Pallayova","year":"2014","journal-title":"Clin Obes"},{"key":"R3-23-20210210","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"issue":"Suppl 2","key":"R4-23-20210210","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s12072-013-9477-5","article-title":"Lean NASH: distinctiveness and clinical implication.","volume":"7","author":"Das","year":"2013","journal-title":"Hepatol Int"},{"key":"R5-23-20210210","doi-asserted-by":"crossref","first-page":"17932","DOI":"10.3748\/wjg.v20.i47.17932","article-title":"Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.","volume":"20","author":"Feng","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R6-23-20210210","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.4254\/wjh.v7.i16.2041","article-title":"Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review.","volume":"7","author":"Whitsett","year":"2015","journal-title":"World J Hepatol"},{"key":"R7-23-20210210","first-page":"645","article-title":"The genetics of NAFLD. Nature reviews.","volume":"10","author":"Anstee","year":"2013","journal-title":"Gastroenterol Hepatol"},{"key":"R8-23-20210210","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/hep.27395","article-title":"The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.","volume":"61","author":"Maximos","year":"2015","journal-title":"Hepatology"},{"key":"R9-23-20210210","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1053\/j.gastro.2012.02.003","article-title":"Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.","volume":"142","author":"Cusi","year":"2012","journal-title":"Gastroenterology"},{"key":"R10-23-20210210","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"R11-23-20210210","doi-asserted-by":"crossref","first-page":"14205","DOI":"10.3748\/wjg.v20.i39.14205","article-title":"Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease.","volume":"20","author":"Paradies","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R12-23-20210210","first-page":"14","article-title":"Endoplasmic reticulum stress and oxidative stress in the pathogenesis of non-alcoholic fatty liver disease.","volume":"1-","author":"Ashraf","year":"2015","journal-title":"Free Radic Res"},{"key":"R13-23-20210210","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1053\/j.gastro.2014.12.036","article-title":"Food, immunity, and the microbiome.","volume":"148","author":"Tilg","year":"2015","journal-title":"Gastroenterology"},{"key":"R14-23-20210210","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/hep.23622","article-title":"Homozygosity for the patatin-like phospholipase-3adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.","volume":"51","author":"Valenti","year":"2010","journal-title":"Hepatology"},{"key":"R15-23-20210210","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/hep.26170","article-title":"Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats.","volume":"57","author":"Kumashiro","year":"2013","journal-title":"Hepatology"},{"key":"R16-23-20210210","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1038\/ncomms5309","article-title":"TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.","volume":"5","author":"Liu","year":"2014","journal-title":"Nat Commun"},{"key":"R17-23-20210210","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease.","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat Genet"},{"key":"R18-23-20210210","doi-asserted-by":"crossref","first-page":"e1001324","DOI":"10.1371\/journal.pgen.1001324","article-title":"Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits.","volume":"7","author":"Speliotes","year":"2011","journal-title":"PLoS Genet"},{"key":"R19-23-20210210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2796.2011.02377.x","article-title":"Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia.","volume":"270","author":"Stadlmayr","year":"2011","journal-title":"J Intern Med"},{"key":"R20-23-20210210","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIVHCV coinfection.","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"R21-23-20210210","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"R22-23-20210210","first-page":"668","article-title":"S2k Guideline non-alcoholic fatty liver disease.","volume":"53","author":"Roeb","year":"2015","journal-title":"Z Gastroenterol"},{"key":"R23-23-20210210","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12881-014-0112-7","article-title":"Genetic polymorphisms at SIRT1 and FOXO1 are associated with carotid atherosclerosis in the SAPHIR cohort.","volume":"15","author":"Kedenko","year":"2014","journal-title":"BMC Med Genet"},{"key":"R24-23-20210210","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity.","volume":"35","author":"Craig","year":"2003","journal-title":"Med Sci Sports Exerc"},{"key":"R25-23-20210210","doi-asserted-by":"crossref","first-page":"W652","DOI":"10.1093\/nar\/gkp356","article-title":"MetaboAnalyst: a web server for metabolomic data analysis and interpretation.","volume":"37","author":"Xia","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"R26-23-20210210","doi-asserted-by":"crossref","first-page":"W251","DOI":"10.1093\/nar\/gkv380","article-title":"MetaboAnalyst 3.0-making metabolomics more meaningful.","volume":"43","author":"Xia","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"R27-23-20210210","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/sim.4780090710","article-title":"More powerful procedures for multiple significance testing.","volume":"9","author":"Hochberg","year":"1990","journal-title":"Stat Med"},{"key":"R28-23-20210210","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"Hainard A et al. pROC: an open-source package for R and S to analyze and compare ROC curves.","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"R29-23-20210210","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/gutjnl-2015-309265","article-title":"Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study.","volume":"65","author":"Kwok","year":"2015","journal-title":"Gut"},{"key":"R30-23-20210210","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MD.0b013e3182779d49","article-title":"Nonalcoholic fatty liver disease in lean individuals in the United States.","volume":"91","author":"Younossi","year":"2012","journal-title":"Medicine"},{"key":"R31-23-20210210","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1365-2036.2006.03112.x","article-title":"Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.","volume":"24","author":"Wong","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R32-23-20210210","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1478-3231.2008.01920.x","article-title":"Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease.","volume":"29","author":"Yun","year":"2009","journal-title":"Liver Int"},{"key":"R33-23-20210210","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1440-1746.2004.03362.x","article-title":"Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men.","volume":"19","author":"Park","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"R34-23-20210210","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ajg.2011.400","article-title":"Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults.","volume":"107","author":"Sinn","year":"2012","journal-title":"A J Gastroenterol"},{"key":"R35-23-20210210","first-page":"663","article-title":"The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease.","volume":"22","author":"Nakamuta","year":"2008","journal-title":"Int J Mol Med"},{"key":"R36-23-20210210","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/apt.12609","article-title":"PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome.","volume":"39","author":"Shen","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"R37-23-20210210","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/apt.13232","article-title":"Patatin-like phospholipase 3 (rs738409) gene polymorphism is associated with increased liver enzymes in obese adolescents and metabolic syndrome in all ages.","volume":"42","author":"Mangge","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"R38-23-20210210","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2337\/db13-0774","article-title":"Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity.","volume":"63","author":"Hyysalo","year":"2014","journal-title":"Diabetes"},{"key":"R39-23-20210210","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.3748\/wjg.v17.i29.3377","article-title":"Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence.","volume":"17","author":"Zelber-Sagi","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R40-23-20210210","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/oby.2009.472","article-title":"Variations in BMI and prevalence of health risks in diverse racial and ethnic populations.","volume":"18","author":"Stommel","year":"2010","journal-title":"Obesity"},{"key":"R41-23-20210210","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0168-8227(99)00041-8","article-title":"Oxidized LDL and expression of monocyte adhesion molecules.","volume":"45","author":"Kita","year":"1999","journal-title":"Diabetes Res Clin Pract"},{"key":"R42-23-20210210","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0005-2760(92)90261-S","article-title":"Altered positional specificity of human plasma lecithin-cholesterol acyltransferase in the presence of sn-2 arachidonoyl phosphatidyl cholines. Mechanism of formation of saturated cholesteryl esters.","volume":"1128","author":"Subbaiah","year":"1992","journal-title":"Biochim Biophys Acta"},{"key":"R43-23-20210210","doi-asserted-by":"crossref","first-page":"e111348","DOI":"10.1371\/journal.pone.0111348","article-title":"Alterations of plasma lysophosphatidylcholine species in obesity and weight loss.","volume":"9","author":"Heimerl","year":"2014","journal-title":"PLoS One"},{"key":"R44-23-20210210","doi-asserted-by":"crossref","first-page":"e0123306","DOI":"10.1371\/journal.pone.0123306","article-title":"Altered plasma lysophosphatidylcholines and amides in non-obese and non-diabetic subjects with borderline-to-moderate hypertriglyceridemia: a case-control study.","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One"},{"key":"R45-23-20210210","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s11745-011-3589-2","article-title":"2-Polyunsaturated acyl lysophosphatidylethanolamine attenuates inflammatory response in zymosan A-induced peritonitis in mice.","volume":"46","author":"Hung","year":"2011","journal-title":"Lipids"},{"key":"R46-23-20210210","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1476-5381.2010.01117.x","article-title":"Mechanisms for anti-inflammatory effects of 1-15(S)-hydroxyeicosapentaenoyl lysophosphatidylcholine, administered intraperitoneally, in zymosan A-induced peritonitis.","volume":"162","author":"Hung","year":"2011","journal-title":"Br J Pharmacol"},{"key":"R47-23-20210210","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.bbrc.2004.11.120","article-title":"Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor.","volume":"326","author":"Soga","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"R48-23-20210210","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/oby.2009.510","article-title":"Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity.","volume":"18","author":"Mihalik","year":"2010","journal-title":"Obesity"},{"key":"R49-23-20210210","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","article-title":"Plasma metabolomic profile in nonalcoholic fatty liver disease.","volume":"60","author":"Kalhan","year":"2011","journal-title":"Metabolism"},{"key":"R50-23-20210210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1758-8111.2012.00039.x","article-title":"Plasma amino acid profile is associated with visceral fat accumulation in obese Japanese subjects.","volume":"2","author":"Yamakado","year":"2012","journal-title":"Clin Obes"},{"key":"R51-23-20210210","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1038\/nutd.2014.38","article-title":"Altered levels of serum sphingomyelin and ceramide containing distinct acyl chains in young obese adults.","volume":"4","author":"Hanamatsu","year":"2014","journal-title":"Nutr Diabetes"},{"key":"R52-23-20210210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1743-7075-3-5","article-title":"Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease.","volume":"3","author":"Schlitt","year":"2006","journal-title":"Nutr Metab"},{"key":"R53-23-20210210","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jhep.2014.11.002","article-title":"Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity.","volume":"62","author":"Anjani","year":"2015","journal-title":"J Hepatol"},{"key":"R54-23-20210210","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/hep.26499","article-title":"Finding the balance: the role of S-adenosylmethionine and phosphatidylcholine metabolism in development of nonalcoholic fatty liver disease.","volume":"58","author":"Jacobs","year":"2013","journal-title":"Hepatology"},{"key":"R55-23-20210210","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jhep.2014.09.023","article-title":"Acid sphingomyelinase-ceramide system in steatohepatitis: a novel target regulating multiple pathways.","volume":"62","author":"Garcia-Ruiz","year":"2015","journal-title":"J Hepatol"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2016318.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2016318","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2016318.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201701000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:13:24Z","timestamp":1786547604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201701000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2016.318","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}